Stockscreener 앱 받기
69.73
0.34%
-0.24
시간 외 거래:
69.73
전일 마감가:
$69.97
열려 있는:
$70.16
하루 거래량:
6.23M
Relative Volume:
3.11
시가총액:
$15.82B
수익:
$4.03B
순이익/손실:
$789.50M
주가수익비율:
20.94
EPS:
3.33
순현금흐름:
$1.15B
1주 성능:
-2.75%
1개월 성능:
-3.50%
6개월 성능:
-11.61%
1년 성능:
-4.54%
1일 변동 폭
$69.72
$70.41
1주일 범위
$68.61
$72.99
52주 변동 폭
$68.61
$84.67
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
HOLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
69.73 | 15.82B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
592.64 | 211.09B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
237.38 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.37 | 41.73B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
239.78 | 35.23B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
336.34 | 24.40B | 2.88B | 499.60M | 321.60M | 6.74 |
홀로직 Stock (HOLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-12-10 | 재확인 | Needham | Buy |
| 2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-27 | 개시 | Stephens | Overweight |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-14 | 업그레이드 | Needham | Hold → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-05 | 재확인 | Needham | Buy |
| 2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 재확인 | Needham | Buy |
| 2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-01-31 | 재확인 | Needham | Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
LaFleur & Godfrey LLC Increases Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Cancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits Research - GlobeNewswire Inc.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - Yahoo Finance
Avanza Fonder AB Purchases Shares of 25,810 Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
The 'coolest thing made in Delaware' may save more than 20,000 lives a year - MSN
Boston Common Asset Management LLC Has $16.41 Million Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
FDA warns Hologic to do more to prevent harm from component in recalled implant markers - Plastics News
Hologic: Reasonably, But Not Compellingly Valued (NASDAQ:HOLX) - Seeking Alpha
Earnings Preview: What To Expect From Hologic's Report - MSN
Hologic Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
BioZorb Lawsuit - Lawsuit Information Center Blog
Breast Cancer Patient Advances Hologic Suit Over BioZorb Device - Bloomberg Law
Hologic receives FDA warning letter over Biozorb implantable markers - MedTech Dive
Biopsy Devices Market Global Report and Company Analysis - GlobeNewswire
Biopsy Devices Market Global Report and Company Analysis 2025-2033 Featuring Cardinal Health, Hologic, Danaher, Becton, Dickinson and Co, Boston Scientific, Medtronic, Olympus, and CONMED - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Receives $88.92 Consensus Target Price from Analysts - MarketBeat
FDA threatens Hologic with punishment for reported errors in making troubled breast device - Radiology Business
Hologic Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Marlborough device maker receives FDA warning regarding implantable devices - The Business Journals
Hologic Hits New 52-Week Low: How to Play the Stock Now? - MSN
Hologic says Q1 EPS expected to be near high end of guidance ranges - MSN
Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Hologic Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Hologic (FRA:HO1) Total Inventories : €613 Mil (As of Sep. 2024) - GuruFocus.com
Benson Investment Management Company Inc. Makes New Investment in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic's (HOLX) "Outperform" Rating Reiterated at William Blair - MarketBeat
Hologic stock hits 52-week low at $70.36 amid market shifts - Investing.com Nigeria
Clean Yield Group Grows Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic (NASDAQ:HOLX) Sets New 1-Year LowWhat's Next? - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for Hologic (NASDAQ:HOLX) Stock Price - MarketBeat
Hologic stock hits 52-week low at $70.36 amid market shifts By Investing.com - Investing.com South Africa
Hologic, Inc. (HOLX) Announces Board Changes Ahead of 2025 Annua - GuruFocus.com
Hologic's (HOLX) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Digital Breast Tomosynthesis Market reached US$ 3.5 billion - openPR
Strategic Acquisitions by Hologic and iCAD Shape Future of CAD Market - openPR
Hologic revenue increases 0.9% to USD 1,021.8M in Q1 2025 - Medical Buyer
Here's What To Make Of Hologic's (NASDAQ:HOLX) Decelerating Rates Of Return - Simply Wall St
Infectious Disease Diagnostics Market Is Booming Worldwide - openPR
Here's Why You Should Retain HOLX Stock in Your Portfolio Now - MSN
Hologic Q1 Revenue Hits $1.02B as Diagnostics Division Leads Growth with 9% Organic Surge - StockTitan
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025 - The Bakersfield Californian
Diversified Trust Co Buys Shares of 7,016 Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Inc announces board changes ahead of annual meeting By Investing.com - Investing.com Canada
Hologic Inc announces board changes ahead of annual meeting - Investing.com India
Hologic, Inc. Announces Director Retirement - Marketscreener.com
BioZorb Lawuit LawyerBreast Biopsy Marker RecallJanuary 2025 Update - Levin Papantonio
First Hawaiian Bank Sells 18,933 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
HIV Diagnostics Test Market Is Booming Worldwide 2025-2032 | - openPR
Is Hologic Stock Underperforming the Dow? - MSN
Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note - MSN
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.10%
2.04%
자본화:
|
볼륨(24시간):